MedTrace Logo

Conventional Photodynamic Therapy vs. Painless Photodynamic Therapy for Actinic Keratosis

NCT04396184 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2020-05-20

No results posted yet for this study

Summary

This study is being done to compare a new, continuous illumination and short Incubation time regimen of aminolevulinic acid photodynamic therapy#ALA-PDT) to a conventional regimen for treatment of Actinic Keratosis. The hypothesis is that the continuous illumination approach will be less or even no painful, but equally efficacious, as the old regimen.

Conditions

  • Actinic Keratosis

Interventions

PROCEDURE

Aminolevulinic acid photodynamic therapy

Aminolevulinic acid photodynamic therapy

Sponsors & Collaborators

  • Shanghai Dermatology Hospital

    lead OTHER

Principal Investigators

  • Xiuli Wang, PHD,MD · Shanghai Skin Disease Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-01
Primary Completion
2021-04-30
Completion
2021-04-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04396184 on ClinicalTrials.gov